Publications by authors named "Daniel M Geynisman"

86Publications

Liquefaction and Rupture of Angiomyolipoma after Embolization.

J Vasc Interv Radiol 2020 Aug 25. Epub 2020 Aug 25.

Department of Medical Oncology, Fox Chase Cancer Center - Temple University Health System, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2020.05.021DOI Listing
August 2020

Incidentally discovered primary mediastinal germ cell tumor.

JAAPA 2020 Apr;33(4):35-37

Victoria Wong practices at Fox Chase Cancer Center in Philadelphia, Pa. Daniel M. Geynisman is an assistant professor of medical oncology at Fox Chase Cancer Center. The authors have disclosed no potential conflicts of interest, financial or otherwise.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JAA.0000657172.30545.a3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534393PMC
April 2020

Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer.

Eur Urol Oncol 2020 02 18;3(1):104-111. Epub 2019 Jul 18.

Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.06.016DOI Listing
February 2020

Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data.

Pharmacoeconomics 2019 12;37(12):1495-1507

Department of Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-019-00824-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885100PMC
December 2019

First-line Immunotherapy in Metastatic Urothelial Carcinoma.

Eur Urol Focus 2020 01 15;6(1):45-47. Epub 2019 May 15.

Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2019.04.015DOI Listing
January 2020

Update on perioperative systemic therapy for urothelial carcinoma.

Clin Adv Hematol Oncol 2019 Mar;17(3):176-183

Fox Chase Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
March 2019

Evolving landscape of the treatment of metastatic clear cell renal cell carcinoma.

Clin Adv Hematol Oncol 2018 Oct;16(10):677-686

Fox Chase Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
October 2018

Mutations in renal cell carcinoma.

Urol Oncol 2020 Oct 23;38(10):763-773. Epub 2018 Nov 23.

Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439183043
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2018.10.027DOI Listing
October 2020

Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review.

Pharmacoeconomics 2019 03;37(3):301-331

Section of Cancer Economics and Policy, Department of Health Services Research, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1444, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-018-0746-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886358PMC
March 2019

What can the National Cancer Database tell us about disparities in advanced bladder cancer outcomes?

Transl Androl Urol 2018 Aug;7(4):732-735

Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tau.2018.06.16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127539PMC
August 2018

Approved checkpoint inhibitors in bladder cancer: which drug should be used when?

Ther Adv Med Oncol 2018 30;10:1758835918788310. Epub 2018 Jul 30.

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918788310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066800PMC
July 2018

Provider and patient burdens of obtaining oral anticancer medications.

Am J Manag Care 2018 04 1;24(4):e128-e133. Epub 2018 Apr 1.

Fox Chase Cancer Center, Temple University Health System, 333 Cottman Ave, Philadelphia, PA 19111. Email:

View Article

Download full-text PDF

Source
April 2018

Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma.

J Clin Oncol 2018 06 11;36(16):1588-1593. Epub 2018 Apr 11.

Eric Jonasch, Rebecca S. Slack, Summer Stovall, Donna Juarez, Troy R. Gilchrist, Lisa Pruitt, and Nizar M. Tannir, The University of Texas MD Anderson Cancer Center; Elshad Hasanov, The University of Texas Health Science Center, Houston, TX; Daniel M. Geynisman and Elizabeth R. Plimack, Fox Chase Cancer Center, Philadelphia, PA; Matthew I. Milowsky, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; W. Kimryn Rathmell, Vanderbilt Ingram Cancer Center, Nashville, TN; and Moshe C. Ornstein and Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.77.1485
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.77.1485DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804828PMC
June 2018

Chemoimmunotherapy in Metastatic Urothelial Carcinoma.

Eur Urol 2018 05 10;73(5):760-762. Epub 2018 Jan 10.

Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.12.029DOI Listing
May 2018

Distress and Financial Distress in Adults With Cancer: An Age-Based Analysis.

J Natl Compr Canc Netw 2017 10;15(10):1224-1233

From Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.0161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569506PMC
October 2017

Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer.

Eur Urol Focus 2018 12 23;4(6):969-971. Epub 2017 Jan 23.

Division of Urological Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2017.01.003DOI Listing
December 2018

Role of collaboration between urologists and medical oncologists in the advanced prostate cancer space.

Urol Oncol 2017 12 15;35(12):665-669. Epub 2017 Jul 15.

Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439173033
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2017.06.046DOI Listing
December 2017

Hope and Uncertainty in the Age of Miracles.

J Palliat Med 2017 10 18;20(10):1166-1169. Epub 2017 May 18.

Department of Hematology/Oncology, Fox Chase Cancer Center, Temple University Health System , Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jpm.2017.0198DOI Listing
October 2017

Bending the Curve of Advanced Urothelial Carcinoma.

J Oncol Pract 2017 05;13(5):319-320

Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.023325DOI Listing
May 2017

Malignant Infiltration of the Penis From Urothelial Carcinoma of the Bladder.

Urology 2017 Sep 31;107:23-25. Epub 2017 Mar 31.

Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2017.03.036DOI Listing
September 2017

Biosimilar biologic drugs: a new frontier in medical care.

Postgrad Med 2017 May 3;129(4):460-470. Epub 2017 Apr 3.

e Global Established Pharma Medicines Development Group , Pfizer Inc , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00325481.2017.1311196DOI Listing
May 2017

Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.

Curr Treat Options Oncol 2017 01;18(1)

Department of Hematology/Oncology, Fox Chase Cancer Center, Temple Health, 333 Cottman Avenue, Philadelphia, PA, 19111-2497, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-017-0458-0DOI Listing
January 2017

Patient-reported and Cost-effectiveness Outcomes Are Key to Determining the Optimal Therapeutic Sequence for Patients with Metastatic Renal Cell Carcinoma.

Eur Urol 2017 02 13;71(2):210-212. Epub 2016 Sep 13.

Medical Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.09.003DOI Listing
February 2017

Checkpoint inhibitors for renal cell carcinoma: current landscape and future directions.

Immunotherapy 2016 06;8(7):785-98

Department of Medical Oncology, Fox Chase Cancer Center, Temple Health, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2016-0028DOI Listing
June 2016

Bladder Preservation Therapy: A Review of the Literature and Future Directions.

Urology 2016 Oct 30;96:54-61. Epub 2016 May 30.

Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2016.05.041DOI Listing
October 2016

Second-generation Androgen Receptor-targeted Therapies in Nonmetastatic Castration-resistant Prostate Cancer: Effective Early Intervention or Intervening Too Early?

Eur Urol 2016 12 26;70(6):971-973. Epub 2016 May 26.

Medical Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.05.026DOI Listing
December 2016

Targeted Therapy for Metastatic Urothelial Cancer: A Work in Progress.

J Clin Oncol 2016 06 9;34(18):2088-92. Epub 2016 May 9.

Fox Chase Cancer Center, Temple Health, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.1420DOI Listing
June 2016

The Parity Paradigm: Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?

Value Health 2016 Jan 26;19(1):88-98. Epub 2015 Nov 26.

Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2015.10.005DOI Listing
January 2016

Drug Supply Chain Security Act and Oral Anticancer Medications: Are We Shortchanging Our Patients?

JAMA Oncol 2016 Mar;2(3):295-6

Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.5345DOI Listing
March 2016

Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma.

Cancer Med 2016 Feb 18;5(2):192-9. Epub 2015 Dec 18.

Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.577DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735777PMC
February 2016

When Patients Leave.

J Clin Oncol 2016 Feb 30;34(5):509-10. Epub 2015 Nov 30.

From Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.2124DOI Listing
February 2016

Muscle-invasive urothelial bladder cancer: an update on systemic therapy.

Ther Adv Urol 2015 Dec;7(6):312-30

Assistant Professor of Medical Oncology, Fox Chase Cancer Center-Temple University Health System, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756287215607418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647143PMC
December 2015

Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features.

Eur Urol 2015 Nov 18;68(5):912-4. Epub 2015 Jul 18.

Department of Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.07.008DOI Listing
November 2015

Osteoclast inhibitors in advanced prostate cancer: does the benefit extend beyond skeletal-related events?

Eur Urol 2015 Oct 23;68(4):578-80. Epub 2015 Jun 23.

Medical Oncology, Fox Chase Cancer Center Temple Health, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.06.009DOI Listing
October 2015

Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011.

J Clin Oncol 2015 Jul 18;33(19):2190-6. Epub 2015 May 18.

Ya-Chen Tina Shih, University of Texas MD Anderson Cancer Center, Houston, TX; Fabrice Smieliauskas, University of Chicago, Chicago, IL; Daniel M. Geynisman, Fox Chase Cancer Center, Philadelphia, PA; Ronan J. Kelly and Thomas J. Smith, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.2320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477789PMC
July 2015

The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Nat Rev Nephrol 2015 Sep 14;11(9):515-34. Epub 2015 Apr 14.

Department of Developmental Therapeutics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneph.2015.46DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902186PMC
September 2015

Metastatic Extramammary Paget's Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature.

Case Rep Oncol Med 2015 27;2015:895151. Epub 2015 Jan 27.

Department of Hematology/Oncology Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/895151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322830PMC
February 2015

Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trials.

Discov Med 2014 Dec;18(101):341-50

Department of Hematology/Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
December 2014

E-mail anonymous: a physician's addiction.

J Clin Oncol 2015 Jan 15;33(3):285-6. Epub 2014 Dec 15.

From the Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.9705DOI Listing
January 2015

Economic evaluation of therapeutic cancer vaccines and immunotherapy: a systematic review.

Hum Vaccin Immunother 2014 ;10(11):3415-24

a Department of Medical Oncology; Fox Chase Cancer Center; Temple Health ; Philadelphia , PA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.29407DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514043PMC
October 2015

Treatment patterns and costs for metastatic renal cell carcinoma patients with private insurance in the United States.

Clin Genitourin Cancer 2015 Apr 28;13(2):e93-100. Epub 2014 Sep 28.

Section of Hospital Medicine, Department of Medicine, University of Chicago, Chicago, IL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.08.013DOI Listing
April 2015

A review of interventional clinical trials in renal cell carcinoma: a status report from the ClinicalTrials.gov WebSite.

Clin Genitourin Cancer 2015 Apr 28;13(2):142-9. Epub 2014 Sep 28.

Department of Medical Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.08.005DOI Listing
April 2015

Coupling of prostate and thyroid cancer diagnoses in the United States.

Ann Surg Oncol 2015 Mar 10;22(3):1043-9. Epub 2014 Sep 10.

Division of Urology, Department of Surgery, MD Anderson Cancer Center at Cooper, Cooper Medical School of Rowan University, Camden, NJ, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-4066-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419700PMC
March 2015

Corticosteroids and prostate cancer: friend or foe?

Eur Urol 2015 May 20;67(5):874-5. Epub 2014 Aug 20.

Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.08.008DOI Listing
May 2015

Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review.

Pharmacoeconomics 2014 Jul;32(7):651-80

Department of Health Studies, The University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-014-0160-zDOI Listing
July 2014

A review of economic impact of targeted oral anticancer medications.

Expert Rev Pharmacoecon Outcomes Res 2014 Feb 30;14(1):45-69. Epub 2013 Dec 30.

Departments of Health Services Research and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2014.868310DOI Listing
February 2014

Reply to M.R. Litzow et al.

J Clin Oncol 2013 Oct 9;31(29):3723-4. Epub 2013 Sep 9.

University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.8431DOI Listing
October 2013

Adherence to targeted oral anticancer medications.

Discov Med 2013 Apr;15(83):231-41

Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, 5841 S. Maryland Ave., Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477693PMC
April 2013

Doctor, where art thou?

J Clin Oncol 2013 Apr 11;31(12):1606-8. Epub 2013 Mar 11.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.2059DOI Listing
April 2013

Toward personalized treatment of advanced biliary tract cancers.

Discov Med 2012 Jul;14(74):41-57

Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
July 2012

Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.

J Thorac Oncol 2011 Nov;6(11 Suppl 4):S1810-1

University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641532645
Publisher Site
http://dx.doi.org/10.1097/01.JTO.0000407568.45147.43DOI Listing
November 2011